Astrazeneca (AZN) Pension (2016 - 2026)

Astrazeneca has reported Pension over the past 17 years, most recently at -$953.0 million for Q1 2026.

For Q1 2026, Pension rose 25.49% year-over-year to -$953.0 million; the TTM value through Mar 2026 reached -$953.0 million, up 25.49%, while the annual FY2025 figure was -$1.1 billion, 183.08% down from the prior year.
Pension for Q1 2026 was -$953.0 million at Astrazeneca, up from -$1.1 billion in the prior quarter.
Over five years, Pension peaked at $1.5 billion in Q4 2023 and troughed at -$2.0 billion in Q1 2022.
A 5-year average of -$791.1 million and a median of -$1.1 billion in 2023 define the central range for Pension.
Biggest five-year swings in Pension: soared 62.47% in 2022 and later plummeted 183.08% in 2025.
Year by year, Pension stood at $1.2 billion in 2022, then soared by 30.14% to $1.5 billion in 2023, then dropped by 12.5% to $1.3 billion in 2024, then plummeted by 183.08% to -$1.1 billion in 2025, then increased by 13.76% to -$953.0 million in 2026.
Business Quant data shows Pension for AZN at -$953.0 million in Q1 2026, -$1.1 billion in Q4 2025, and -$1.3 billion in Q3 2025.

Peer Comparison